Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ARRAY BIOPHARMA INC Financial Overview

  • Income Statement: ARRY

      2009 2008 Change ( 2008 - 2009  )
    Net Sales/Revenues 24.98 M 28.81 M -3.83 M -15.32%
    Gross Profit 5.40 M 7.44 M -2.05 M -37.95%
    Net Income Before Extra Items/Preferred Div -127.82 M -96.29 M -31.53 M 24.67%
    Operating Income -100.94 M -98.49 M -2.45 M 2.43%
  • Cash Flow: ARRY

      2009 2008 Change ( 2008 - 2009  )
    Net Cash Flow - Financing 40.69 M 40.79 M -100,000.00 -0.25%
    Net Cash Flow - Investing -29.00 M -50.73 M 21.72 M -74.89%
    Net Cash Flow/Operating Activities -92.94 M -45.74 M -47.20 M 50.79%
  • Balance Sheet: ARRY

      2009 2008 Change ( 2008 - 2009  )
    Total Assets 95.06 M 163.08 M -68.02 M -71.56%
    Total Liabilities 168.76 M 125.05 M 43.71 M 25.90%
    Shareholders Equity -73.70 M 38.03 M -111.73 M 151.60%
  • Key Ratios / Statistics: ARRY

    • Valuation

      Price/Earnings (TTM) -1.51
      Price/Sales (TTM) 6.65
      Price/Book (MRQ) -1.39
      Price/Cash Flow (TTM) -1.14
    • Profitability

      Gross Margin 21.60
      Operating Margin -404.07
      Profit Margin -511.63
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 0.81
      Current Ratio (MRQ) 1.75
      Long Term Debt-to-Equity (MRQ) -131.06
    • Management Effectiveness

      Return on Equity (TTM) -561.27
      Return on Assets (TTM) -90.24
      Return on Investments (TTM) -292.81